Cognitive Neuroscience Division of the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University College of Physicians and Surgeons, 630 West 168(th)St, P&S 16, New York, NY, 10032, USA; Department of Neurology, Columbia University College of Physicians and Surgeons, 710 West 168(th)St, New York, NY, 10032, USA.
Department of Psychiatry, Columbia University College of Physicians and Surgeons, 1051 Riverside Dr, New York, NY, 10032, USA; Division of Geriatric Psychiatry, New York State Psychiatric Institute, New York, NY, USA.
Behav Brain Res. 2021 Mar 26;402:113078. doi: 10.1016/j.bbr.2020.113078. Epub 2021 Jan 5.
Olfactory dysfunction consistently occurs in patients with Alzheimer's disease (AD), beyond the mild and gradual decline in olfactory ability found in normal aging. This dysfunction begins early in the disease course, typically before clinical diagnosis, and progresses with disease severity. While odor identification and detection deficits clearly differentiate AD from controls, there remains uncertainty as to whether these are determined by olfactory threshold. The purpose of the current preliminary fMRI study was to examine the neural correlates of olfactory processing in healthy young and old adults and compare them with AD patients. We also explored the interplay between age and disease-related psychophysical olfactory declines and odorant-induced brain activation. Results indicated AD patients had decreased odor detection task-related signal in all regions of the primary olfactory cortex, with activity in the entorhinal cortex best differentiating the groups. Moderated-mediation analyses on neuro-psychophysical relationships found that increased brain activation in the entorhinal cortex moderated the negative effect of disease-related threshold changes on olfactory detection. Therefore, even in the face of higher (worse) olfactory thresholds, older adults and AD patients compensated for this effect with increased brain activation in a primary olfactory brain region. This was the case for odor detection but not odor identification. fMRI activation induced by an olfactory detection task may eventually be useful in improving early discovery of AD and may, eventually, facilitate early treatment interventions in subjects at risk for AD.
嗅觉功能障碍在阿尔茨海默病(AD)患者中持续存在,超出了正常衰老中嗅觉能力的轻度和逐渐下降。这种功能障碍在疾病早期发生,通常在临床诊断之前,并随着疾病严重程度的发展而进展。虽然气味识别和检测缺陷明显将 AD 与对照组区分开来,但仍不确定这些是否由嗅觉阈值决定。目前初步 fMRI 研究的目的是检查健康年轻和老年成年人嗅觉处理的神经相关性,并将其与 AD 患者进行比较。我们还探讨了年龄和与疾病相关的心理物理学嗅觉下降以及气味诱导的大脑激活之间的相互作用。结果表明,AD 患者在初级嗅觉皮层的所有区域的气味检测任务相关信号都减少了,而内嗅皮层的活动最能区分两组。对神经心理物理学关系的中介分析表明,内嗅皮层的大脑激活增加调节了与疾病相关的阈值变化对嗅觉检测的负面影响。因此,即使面对更高(更差)的嗅觉阈值,老年人和 AD 患者也通过增加初级嗅觉脑区的大脑激活来对此进行补偿。这种情况适用于气味检测,但不适用于气味识别。嗅觉检测任务引起的 fMRI 激活最终可能有助于提高 AD 的早期发现,并最终促进 AD 高危人群的早期治疗干预。